Motion sickness is majorly associated with frequent travel where in the brain is not able to sense and process the information that is sent from eyes, ears, and the nose. It makes one feel clumsier, an increased feeling of frequent nausea, and high fever in certain cases. In addition to travel, hormonal birth control, family history of motion sickness, migraines, and Parkinson’s disease may lead to increased chances of acquiring motion sickness. Additionally, certain situational and macro-environmental factors are involved with onset of motion sickness, which include amusement park rides, reading while moving backward, and increased screen time. Most visual symptoms associated with motion sickness include frequent headache, irritability, cold sweats, inability to concentrate on one particular thing, and pale skin.

Motion sickness treatment includes incorporation of anti-histamines, which include clemastine and fexofenadine. In addition, scopolamine skin patches are used in highly developed nations with high disposable income patient groups. The patch is regularly changed after 3-4 days resulting in visual positive results. In addition to therapeutic techniques, in civilizational states such as India, people make use of herbs such as neem, ginger, and lavender to get rid of motion sickness. In few other cases, adequate supplementary diet, drinking patters, and use of acupressure to balance off the pressure points may help in aiding motion sickness treatment.

Market Scope and Structure Analysis

COVID-19 Impact Analysis

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected to witness a significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19. This, in turn, is expected to have a significant impact on the motion sickness treatment market.

Top Impacting Factors

• Rise in the number of travelers, including air travelers, road travelers, and waterway travelers, and the subsequent incidents of cardiovascular syndromes especially among young and geriatric population are the foremost factors anticipated to lead market growth for motion sickness treatment market.
• Recent research incidents pertaining to design and development of advanced therapeutic drugs with respect to motion sickness is anticipated to gain huge market traction in highly industrialized as well as high population base regions.
• However, recent development and launch of transdermal scopolamine patches is likely to hamper the market.
• Additionally, lack of awareness regarding new age therapeutic drugs specifically in underdeveloped economies may lead to lower penetration, thus hampering the overall growth.
• Inception of non-pharmacological treatment countermeasures to get rid of motion sickness in highly developed nations combined with high disposable income available in these populations is likely to restrain the growth of the market.

Key Market Trends

• North America is anticipated to gain high traction, owing to increased travel across the region combined with the underlying demand for advanced therapeutics to treat motion sickness among patients.
• Among the treatment types, anticholinergic segment is anticipated to dominate the market, owing to better relief mechanism, higher efficacy, positive patient feedback, and fewer side effects.
• Based on distribution channel, online pharmacy and ecommerce is expected to dominate the market, owing to shift toward omnichannel purchase patterns, high penetration of internet in urban & semi urban regions, and most importantly the ease of utility.
• Recently, Dramamine, an OTC motion sickness drug, was repositioned and subsequently re-launched as a children specific treatment.
• Conception of Nauseogenic vehicles for providing additional stability in the body with the help of sensory motor technology is being sort after and currently undergoing clinical trials in research labs around the globe.

Key Segments Covered

Key Benefits of the Report

• This study presents the analytical depiction of the motion sickness treatment industry along with the current trends and future estimations to determine the imminent investment pockets.
• The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the market share.
• The current market is quantitatively analyzed from 2020 to 2030 to highlight the growth scenario.
• Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
• The report provides a detailed analysis depending on competitive intensity and how the competition will take shape in the coming years.

Questions Answered in the Motion Sickness Treatment Report

• Which are the leading players active in the motion sickness treatment market?
• How is each segment of the market expected to grow during the forecast period?
• What are the adoption trends for the motion sickness treatment market in emerging economies and established economies across the world?
• What are the current trends that will influence the market in the next few years?
• What are the driving factors, restraints, and opportunities of the market?
• What future projections would help in taking further strategic steps?
• What are the impacts of COVID-19 in the industry?
• What is motion sickness treatment?
• What is the motion sickness treatment market prediction in the future?
• What are the current trends and predicted trends?